Can I read Prognostic Factors in Male Urethral Cancer on EtoBox?

Prognostic Factors in Male Urethral Cancer by Farhang Rabbani is a Medicine article available to read on EtoBox.

What is Prognostic Factors in Male Urethral Cancer about?

## Abstract ## BACKGROUND: Male urethral cancer is a rare neoplasm, with the published literature consisting of small single‐institution retrospective series. As such, there is no objective analysis of prognostic factors and treatment outcome. The author sought to use the population‐based Surveillance, Epidemiology, and End Results (SEER) database to evaluate prognostic factors in male urethral cancer. ## METHODS: From 1988 to 2006, 2065 men were identified in the SEER database as having primary urethral cancer. Median follow‐up was 2.5 years. Cancer‐specific and overall survival was computed using the Kaplan‐Meier method, and Cox proportional hazards analysis was used to evaluate patient age at diagnosis, year of diagnosis, race, histologic type, grade, T stage, nodal status, M stage, extent of surgery, and type of radiation as potential significant independent predictors of survival. ## RESULTS: Overall survival at 5 and 10 years was 46.2% (95% confidence interval [CI], 43.9‐48.6%) and 29.3% (95% CI, 26.6‐32.0%), respectively, whereas cancer‐specific survival at 5 and 10 years was 68.0% (95% CI, 65.5‐70.5%) and 60.1% (95% CI, 57.0‐63.2%), respectively. Advanced age, higher grade,

Who reads Prognostic Factors in Male Urethral Cancer?

Author

Farhang Rabbani

Publisher

John Wiley and Sons; Wiley (John Wiley & Sons); John Wiley & Sons Inc.; Wiley (ISSN 0008-543X)

Published

2010

Language

EN

Field

Medicine (Health Sciences)